G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 8 450 KRW -8.35% Market Closed
Market Cap: 374.4B KRW
Have any thoughts about
GI Innovation Inc?
Write Note

Relative Value

The Relative Value of one GI Innovation Inc stock under the Base Case scenario is 13 585.09 KRW. Compared to the current market price of 8 450 KRW, GI Innovation Inc is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13 585.09 KRW
Undervaluation 38%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
15
Median 3Y
114.1
Median 5Y
114.1
Industry
7.6
Forward
1.9
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-9.3
Industry
22.1
Forward
1.7
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-12.5
Industry
21.9
vs History
vs Industry
Median 3Y
-12.1
Median 5Y
-12.1
Industry
23.4
vs History
4
vs Industry
9
Median 3Y
7.3
Median 5Y
7.3
Industry
2.5
vs History
27
vs Industry
12
Median 3Y
103.3
Median 5Y
103.3
Industry
7.5
Forward
1.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
4.2
Forward
2.6
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
4
Forward
2.7
vs History
vs Industry
Median 3Y
-11.5
Median 5Y
-11.5
Industry
5.9
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.4
Industry
3.9
vs History
4
vs Industry
17
Median 3Y
13.4
Median 5Y
13.4
Industry
4.5

Multiples Across Competitors

Competitors Multiples
GI Innovation Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
GI Innovation Inc
KOSDAQ:358570
373.4B KRW 78.5 -8 -8.9 -8.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4 33.5 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1 915.4 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6 -213.4 21 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6 16.6 15.1 16.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.4 -136.2 -110 -80.2
P/S Multiple
Revenue Growth P/S to Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average P/S: 3 457 247.1
78.5
1 096%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.4
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average P/E: 211.7
Negative Multiple: -8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBITDA: 16.2
Negative Multiple: -8.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -110 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBIT: 21.2
Negative Multiple: -8.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.2 N/A N/A

See Also

Discover More
Back to Top